![](/img/cover-not-exists.png)
1122PInterim analysis of a single arm phase II study of adjuvant nivolumab after salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy
Wise-Draper, T, Haque, S, Steele, A, Desai, S, Harris, T, Riaz, M K, Morris, J C, Takiar, V, Nagasaka, M, Jandarov, R, Sukari, AVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz252.014
Date:
October, 2019
File:
PDF, 92 KB
2019